First Department of Medicine, Faculty of Medicine Mannheim, University Medical Centre Mannheim (UMM), University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) Partner Site Heidelberg/Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Clinic for Diagnostic and Interventional Radiology Heidelberg, University Heidelberg, Heidelberg, Germany.
Clin Res Cardiol. 2019 Jun;108(6):669-682. doi: 10.1007/s00392-018-1396-y. Epub 2018 Dec 21.
The study sought to assess the prognostic impact of chronic kidney disease (CKD) and renal replacement therapy (RRT) in patients with ventricular tachyarrhythmias and sudden cardiac arrest (SCA) on admission.
A large retrospective registry was used including all consecutive patients presenting with ventricular tachycardia (VT), fibrillation (VF) and SCA on admission from 2002 to 2016. Non-CKD vs. "CKD without RRT", and "CKD without RRT" vs. "CKD with RRT" were compared applying multivariable Cox regression models and propensity-score matching for evaluation of the primary prognostic endpoint defined as long-term all-cause mortality at 2 years. Secondary prognostic endpoints were cardiac death at 24 h, in-hospital death at index and the composite endpoint of recurrent ventricular tachyarrhythmias, appropriate ICD therapies and cardiac death at 24 h.
In 2686 unmatched high-risk patients with ventricular tachyarrhythmias and SCA, non-CKD was present in 46%, "CKD without RRT" in 46% and "CKD with RRT" in 8%. Each, VT and VF occurred in about one-third of CKD patients. Multivariable Cox regression models revealed that "CKD without RRT" (HR = 2.118; p = 0.001) and "CKD with RRT" (HR = 3.043; p = 0.001) patients were associated with the primary endpoint of long-term mortality at 2 years, which was also proven after propensity-score matching (non-CKD vs. "CKD without RRT": 43% vs. 27%, log rank p = 0.001; HR = 1.847; "CKD without RRT" vs. "CKD with RRT": 74% vs. 51%, log rank p = 0.001; HR = 2.129). The rates of secondary endpoints were higher for cardiac death at 24 h, in-hospital death at index and the composite of recurrent ventricular tachyarrhythmias, appropriate ICD therapies and cardiac death at 24 h, respectively, for "CKD without RRT" and "CKD with RRT" patients. CONCLUSION: In patients presenting with ventricular tachyarrhythmias and aborted SCA on admission, the presence of CKD, especially combined with RRT, is independently associated with an increase of long-term all-cause mortality at 2 years, cardiac death at 24 h, in-hospital death and the composite of recurrent ventricular tachyarrhythmias, appropriate ICD therapies and cardiac death at 24 h.
本研究旨在评估慢性肾脏病(CKD)和肾脏替代治疗(RRT)对入院时伴有室性心动过速(VT)、颤动(VF)和心搏骤停(SCA)患者预后的影响。
本研究使用了一个大型回顾性登记数据库,纳入了 2002 年至 2016 年期间所有因 VT、VF 和 SCA 入院的连续患者。非 CKD 与“无 RRT 的 CKD”以及“无 RRT 的 CKD”与“有 RRT 的 CKD”分别进行多变量 Cox 回归模型和倾向评分匹配分析,以评估 2 年时定义为长期全因死亡率的主要预后终点。次要预后终点为 24 小时心脏性死亡、指数内住院死亡以及 24 小时时复发性室性心动过速、适当的 ICD 治疗和心脏性死亡的复合终点。
在 2686 例未匹配的伴有室性心律失常和 SCA 的高危患者中,非 CKD 患者占 46%,“无 RRT 的 CKD”患者占 46%,“有 RRT 的 CKD”患者占 8%。每三例 CKD 患者中就有一例发生 VT 和 VF。多变量 Cox 回归模型显示,“无 RRT 的 CKD”(HR=2.118;p=0.001)和“有 RRT 的 CKD”(HR=3.043;p=0.001)患者与 2 年时的长期死亡率主要终点相关,这一结果在倾向评分匹配后仍然成立(非 CKD 与“无 RRT 的 CKD”:43%比 27%,log rank p=0.001;HR=1.847;“无 RRT 的 CKD”与“有 RRT 的 CKD”:74%比 51%,log rank p=0.001;HR=2.129)。对于“无 RRT 的 CKD”和“有 RRT 的 CKD”患者,24 小时心脏性死亡、指数内住院死亡以及复发性室性心动过速、适当的 ICD 治疗和 24 小时心脏性死亡的复合终点发生率更高。
在因 VT 入院并伴有心脏骤停的患者中,CKD 的存在,尤其是合并 RRT,与 2 年时全因死亡率增加、24 小时心脏性死亡、指数内住院死亡以及复发性室性心动过速、适当的 ICD 治疗和 24 小时心脏性死亡的复合终点相关。